Moderna Covid vaccine sales plunge in 2023, but meet company forecast
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their…
Stocks making the biggest moves midday: MRNA, AAPL, GDRX, COIN
Check out the companies making headlines in midday trading. Moderna — The drugmaker jumped 16% following an upgrade to outperform by Oppenheimer. The firm said Moderna’s multiple product launches in…
10-year Treasury yield is little changed after cool inflation data
The core personal consumption expenditures price index, the Federal Reserve’s preferred core inflation metric, increased 0.1% for the month of November, and was up 3.2% from a year ago, the…
Health sector themes to watch in 2024
An employee works on the production line of pharmaceutical company Zentiva in Prague, Czech Republic, May 6, 2021. David W. Cerny | Reuters The health-care sector has wiped out much…
Treasury yields fall as traders assess prospects of future Fed rate cuts
The 10-year U.S. Treasury yield retreated on Tuesday as traders continued to assess the prospect of future rate cuts from the Federal Reserve. The yield on the benchmark 10-year note…
Moderna, Merck cancer vaccine reduces risk of skin cancer return
An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck’s experimental cancer vaccine, when used in combination with Merck’s blockbuster…
Covid vaccine rates are falling in U.S.
A sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder | Reuters Three years into the Covid-19 pandemic, few Americans are…
Moderna (MRNA) Q3 earnings report 2023: Covid vaccine losses
Moderna on Thursday posted a steep loss for the third quarter as it recorded a large write-down due to unused doses of its Covid vaccine, its only marketable product, and…
Pfizer (PFE) Q3 earnings report 2023
Pfizer on Tuesday reported a narrower-than-expected adjusted loss for the third quarter as the drugmaker recorded charges largely related to struggles for its Covid antiviral treatment Paxlovid and the Covid…
These stocks reporting next week typically beat the Street and rally
Wall Street is bracing for another busy week of earnings as the reporting period reaches its halfway point — and certain stocks are likely to perform better on the back…